Association of intravitreal and topical anti-inflammatory therapies on short-term anatomical and functional outcomes following epiretinal membrane surgery

Retinal Diseases

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Ophthalmol Retina

Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC

doi: 10.1016/j.oret.2025.05.025

Macular Diseases

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Clin Exp Ophthalmol

Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA

doi: 10.1111/ceo.14559

RECOMMENDED

Surgery and InterventionCataracts

Risk of Cataract Surgery Complications in Patients with Prior Intravitreal Injection Therapy

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

Am J Ophthalmol

Zhao CS, Chwialkowski K, Wai KM, Mruthyunjaya P, Rahimy E, Koo EB

doi: 10.1016/j.ajo.2025.01.004

Macular Diseases

Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis

Acta Ophthalmol

Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y

doi: 10.1111/aos.17506

Macular Diseases

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema

BMC Ophthalmol

Singh RP, Tabano D, Kuo BL, LaPrise A, Leng T, Kim E, Hatfield M, Garmo V

doi: 10.1186/s12886-024-03797-9

Retinal DiseasesSurgery and InterventionCataracts

Factors Associated with Retinal Detachment Following Pediatric Cataract Surgery in the IRIS® Registry

Ophthalmology

Altamirano F, Jeon JH, Lee JY, Elze T, Miller JW, Lorch AC, VanderVeen DK, Gonzalez E, Oke I, IRIS® Registry Analytic Center Consortium

doi: 10.1016/j.ophtha.2025.03.003

Glaucoma and Ocular PressureSurgery and Intervention

Long-term outcomes of trabeculectomy versus canaloplasty in open-angle glaucoma - an 11-year follow-up of the TVC study cohort

BMC Ophthalmol

Verma-Fuehring R, Matlach J, Klink T, Hillenkamp J, Grehn F

doi: 10.1186/s12886-025-04183-9

Glaucoma and Ocular PressureRetinal Diseases

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Br J Ophthalmol

Paris A, Volpe G, Perruchoud-Ader K, Casanova A, Menghini M, Grimaldi G

doi: 10.1136/bjo-2024-326053

Glaucoma and Ocular PressureSurgery and InterventionCataracts

Refractive Outcomes Following Combined Cataract and Micro-Invasive Glaucoma Surgery

Ophthalmol Glaucoma

Shaheen A, Afflitto GG, Swaminathan SS

doi: 10.1016/j.ogla.2024.07.003

Related content

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Risk of Cataract Surgery Complications in Patients with Prior Intravitreal Injection Therapy

Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema

Factors Associated with Retinal Detachment Following Pediatric Cataract Surgery in the IRIS® Registry

Long-term outcomes of trabeculectomy versus canaloplasty in open-angle glaucoma - an 11-year follow-up of the TVC study cohort

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Refractive Outcomes Following Combined Cataract and Micro-Invasive Glaucoma Surgery